TheraCea Pharma is a biotechnology company that develops precision medicine to help people with neurological disorders.
TheraCea Pharma is a biotechnology company that develops precision medicine to help people with neurological disorders. TheraCea Pharma, a University of Arizona spin-off based in Tucson, developed and licensed radiochemistry technology that allows for high-efficiency and rapid fluorine-18 radiolabeling of biomolecules for clinical and research applications.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 15, 2021 | Grant | $256K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |